Ipilimumab [ipilimumab]
topical
253
- Terms
-
Yervoy
-
Anti-CTLA-4 MAb Ipilimumab
MDX 010
MDX-010
MDX-CTLA-4
MDX010
Yervoy
Persistent link
https://www.medvik.cz/link/D000074324
Definition
An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
- DUI
- D000074324 MeSH Browser
- CUI
- M000626138
- History note
- 2018(2012)
- Public note
- 2018; IPILIMUMAB was indexed under ANTIBODIES, MONOCLONAL, 2012-2017
Allowable subheadings
- AD
- administration & dosage 53
- AE
- adverse effects 32
- AN
- analysis
- BI
- biosynthesis
- BL
- blood 1
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics 2
- GE
- genetics
- HI
- history
- IM
- immunology 1
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 3
- PD
- pharmacology 39
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use 116
- TO
- toxicity 3
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs